Evidence map›Paper›PMID 31409318›Full record

ArticleBMC infectious diseases2019

Clinical benefits of FilmArray meningitis-encephalitis PCR assay in partially-treated bacterial meningitis in Israel.

Yair Mina, Vered Schechner, Michal Savion, Dafna Yahav, Efraim Bilavsky, Nadav Sorek, Haim Ben-Zvi, Amos Adler

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in BMC infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Observational
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Yair MinaSackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. yairmi@tlvmc.gov.il.ORCID http://orcid.org/0000-0003-2311-6623
Vered SchechnerSackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Michal SavionTel-Aviv District, Israel Ministry of Health, Tel-Aviv, Israel.
Dafna YahavSackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Efraim BilavskySackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Nadav SorekMicrobiology Laboratory, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.
Haim Ben-ZviSackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Amos AdlerSackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Tel Aviv University · ILIsrael Ministry of Health · ILRabin Medical Center · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundManagement of partially-treated, community-acquired bacterial meningitis (PCBM) is commonly compromised by lack of microbiological diagnosis. We aimed to analyze the impact of FilmArray Meningitis-Encephalitis (FA-ME) PCR on the management of PCBM.

methodsComparison of treatment variables of PCBM cases between two periods, before (6.5 years, control group) and after (2 years, study group) the application of FA-ME PCR assay.

resultsThe total duration of antimicrobial treatment in the study group (n = 8) was significantly shorter than the control group (n = 23) (9.5 ± 3.7 days vs. 15.2 ± 5 days, p = 0.007). The percentage of narrow-spectrum regimens was significantly higher in the study group (78 ± 11% vs. 40 ± 9%, p = 0.03). There was a significant difference in implementation of antimicrobial chemoprophylaxis for close contacts (4/8 (50%) vs. 1/23 (4%), p = 0.01).

conclusionsThe use of FA-ME PCR provides significant benefits in the management of PCBM by shortening duration of antibiotic treatment, increasing the use of narrow-spectrum regimens, and allowing proper administration of antimicrobial chemoprophylaxis.

trial registrationThe study was approved and retrospectively registered by the Tel-Aviv Sourasky Medical Center ( 0378-17-TLV , 10/17/2017) and Rabin Medical Center ( 0270-18-RMC , 11/11/2018) Ethics committees and conforms to recognized standards.

Indexed as

AdultAnti-Bacterial AgentsChemopreventionCohort StudiesCommunity-Acquired InfectionsEncephalitisFemaleHumansIsraelMaleMeningitis, BacterialMiddle AgedPolymerase Chain ReactionRetrospective StudiesTime FactorsTreatment OutcomeAnti-Bacterial AgentsBacteriologyMeningitisPolymerase chain reaction

Identifiers

PMID31409318
PMCPMC6693273
OpenAlexW2968540890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.